Beta Bionics, Inc.
BBNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.3% | 31.7% | -13.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.5% | 53.8% | 50.9% | 57.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -49.6% | -69.8% | -102.3% | -86% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52.1% | -72.6% | -162.5% | -88.6% |
| EPS Diluted | -0.33 | -0.39 | -0.93 | -0.42 |
| % Growth | 15.4% | 58.1% | -121.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |